Theralase Technologies Inc. V.TLT

Most under valued or just a p.o.s. stock?

[Biggainer]

I never understood this company. Even when they have good news, the stock price keeps going down. What other company with phase 2 in progress has market cap worse than this company?
Who is manipulating the price? I want to buy this stock, but I know it'll be sitting at these prices for months and months, even if it goes up it'll most likely come right back down again. Seems like someone is purposely depressing the price.  Who in their right mind sell a phase 2 company with so much potential at these prices, they should be buying and accumulating.  Some thing is wrong.

[Retireyoung]

I am with you on this one. I am starting to get impatient but I guess if someone is manipulating the price that is what they want us to feel. This is one of the more frustrating stocks that I have ever held for sure.

[Rumpl3StiltSkin]

If you guys aren't bashers, I'll guess for now, please wait until after TLT announces their 5th & 6th treatment sites in the US, maybe there will be more on the Covid front by then also. Then you can at least make a lil, or lose less...

[Retireyoung]

Definitely not a basher. Have high hopes for this stock but it just can't ever get traction. I will continue to hold it as I think everything they are doing is fantastic but at some point the share price needs to reflect that.

[Rumpl3StiltSkin]

Ok, Yes, I agree. I've done my share of whining over the years. I've had people accuse me of bashing before, lol. I'm holding until I know this isn't going to work out. So far it seems they are still on track.

[CancerSlayer]

  Being a speculative, but promising, biotech (as opposed to an established/revenue-based company), the day-to-day, month-to-month, or even year-to-year pps means little to me on this exchange.  Promising/superior data is king.  With superior data on 20-25 patients, a BTD in place, & continued good news from U of M, Roswell & other research, we will be RIPE for the taking.

[menoalittle]

>> imo, our ACT progress is closely being watched by all players that matter.   most assuredly, that's not your opinion alone. >> Their bidding/buyout strategies are likely already in place : ). hmmm...  seems I'll have to disagree with you on that. 'cause I'm much more inclined to think there ain't a one of them that gots a strategy that's

[skys1]

I believe there is a major, very experienced buyer operating in the wings. My position on the stated idea - A bidding/buyout strategy is already in place, is the following. In a year or so whoever is sitting on this stock will make a hostile takeover offer for maybe 2 or 3 bucks(about 1 $billion). By then shareholders will be so disgusted and depressed more than 50% of them will jump at it, and

[Retireyoung]

If someone bought this company out and we got 3 dollars a share I could retire. Doesn't sound terrible to me!

[StevenBirch]

It's not terrible but we are talking about fair value so ... nudge that decimal place over one spot then we're talking. I don't think Roger would have amassed 7 million shares to sell at $3 because there are a ton of stocks that could go from $0.30 to $3.00 so if that was the goal he should probably spread his risk around. It may sound greedy but it also speaks to his confidence.

[charlierock]

I just agreed with what Birch just said. OMG what's happening?

[StevenBirch]

Unity?

[Jaro1977]

no f'n way  $3 USD tell me when you out? = $3 USD = $13 USD = $33 USD = $80 USD = $150 USD = $500 USD = $2,500 Usd AN F'N CURE FOR CANCER FOLKS

[menoalittle]

hey, I'm not greedy.  I'd be happy enough with the middle number. call it  80. but if you want to take it higher, I'm okay with that too... lol.

[Jaro1977]

yeaaahhhh woooohh

[gojotv!]

Jaro... one word. Dividends. When the stock hits anywhere over $300/share, I may sell half my position, to set myself up, and use future dividends for cash flow for life. And maybe not. I may sell only a quarter, or a fifth... By then, Theralase will have become Canada's first blockbuster Pharma-Tech corporation, creating great-paying jobs for our educated, motivated youth. (Another form of

[Biggainer]

gojotv, I love your enthusiasm. TLT should be trading in the dollar range, but for some reason, it's having a hard time getting there. I see so many biotech stocks in it's preclinical stage and is worth multiple of what Theralase market cap is. I just don't understand how they value these biotech companies. They have the potential to cure certain kinds of cancers. Think about it, out

[CancerSlayer]

Yep...those response rates were encouraging, & the one that had no response (that is, stable or unchanged CIS disease) could become a CR with the 2nd treatment....just as the partial responders have a chance to become, & the TBDs (if they show stable disease or better).  Excited to see data on patients who will have received "two optimized" treatments.  The P.O.S. stock

[Jaro1977]

gojotv!  you may my day, thanks!  Great way to think about it.  Love it.  TLT all the way!!!!!

[gojotv!]

I@ve been wondering why TLT hasn@t had a publicity push following this week@s game-changing news. And then it dawned on me. They have to release what they now know, to avoid @insider knowledge@ issues. I@m sure these Phase2 results are all the buzz in the offices. But for public consumption, it@s far more impactful to release news of a 67% COMPLETE RESPONSE rate once the @unknown@ two patients are

[gojotv!]

I've also been wondering why it's taken repeated attempts to write one lousy post today, as the stockhouse page crashed repeatedly, and the result of my fourth effort posted as such an illegible mess. But hey, I know my opinions aren't beloved by bashers on this site, and organized crime is as organized crime does... Just sayin'. Here's a cleaned-up copy... (Sorry about the

[Rumpl3StiltSkin]

Yeah, Even an unknown Cancer stock on the Venture should see an early buyout offer of $2Bil minimum. Especially if they have an obvious pipeline developing and a solid treatment for Covid 19. $2Bil US is currently valued at ~ $7  SP.

[StevenBirch]

It's been floated before maybe a licensing deal for bladder and further the other indications before accepting a more fair buyout. That way those happy with a quicker outcome can make their own decision, $7 isn't chopped liver, and those not so eager could take some off the table and let the rest ride for the final payday! Nice problems to have.

[O12009]

I thought it was go it alone for bladder and a licensing deal for lung and GBM   With a buyout coming shortly after for 8 billion US

[StevenBirch]

I'm OK with that.

[skys1]

012009, that isn't quite what the plan was back then. Several years ago before Shawn, Roger & Dr. Mandel wanted to keep No. America or at least the U S, and license out Theralase's ACT for and to the rest of the world, to who ever could do a good job of administering. They obviously wanted to stay inthe mix. Since Shawn, things could have changed. However, what they want and what they

[riverrrow]

I think at one time I hoped to sell my shares at $15 but I'm holding so many warrants now I guess I could settle for $11. GLTA.

[gojotv!]

I have to agree... there is something very strange going on... This is the holy grail of modern medicine, admittedly eclipsed by the coronavirus for now, but, still... 22 cents?! I wouldn't be surprised if there was a sneaky takeover attempt underway.

[Biggainer]

Who would sell down to $0.20? Definite manipulation.  Stay away from this stock, will lose all your money.  They have been trading it down for 2 years.

[Infinity]

I am with you on this,  Did notice a huge block of Sell orders just under the 50 cents mark.  Looks like someone does not want this stock to reach the 50 cents!!  I almost get the impression  that the warrants outstanding at 50 cents will expire in October 2022 and not extended?? Inspite of this I went ahead and picked up some more stock at 0.315 and 0.32.  Much against my